Skip to main content

Market Overview

Mid-Day Market Update: U.S. Stocks Turn Positive; Akcea Therapeutics Shares Jump


Midway through trading Monday, the Dow traded up 0.08% to 26594.58 while the NASDAQ rose 0.19% to 7997.36. The S&P also rose, gaining 0.10% to 2,954.85.

Leading and Lagging Sectors

Communication services shares climbed 0.4% on Monday. Meanwhile, top gainers in the sector included Eros International Plc (NYSE: EROS), up 11%, and Daily Journal Corporation (NASDAQ: DJCO), up 4%.

In trading on Monday, utilities shares fell 0.5%.

Top Headline

Intersect ENT Inc (NASDAQ: XENT), which focuses on products for patients with ear, nose and throat conditions, said a study dubbed ASCEND that evaluated its drug-coated sinus balloon for dilation of the frontal sinus ostium did not meet the primary endpoint.

The benchmark was an intra-patient comparison of frontal sinus patency grade at day 30, as judged by an independent reviewer. The drug used was mometasone furoate. The ASCEND study looked at whether the drug-coated sinus balloon would reduce post-balloon dilation edema through localized delivery directly to the dilated tissue.

Equities Trading UP

Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares shot up 32% to $19.93 after the company announced it would receive a $125 million upfront payment from Pfizer for the exclusive licensing of AKCEA-ANGPTL3-L.

Shares of Aethlon Medical, Inc. (NASDAQ: AEMD) surged 22% to $0.3000 after the company announced it received an FDA approval for its IDE for Oncology Indications.

Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) was up, rising 23% to $0.3080 after the company filed 510(k) with the FDA for SNA-001.

Equities Trading DOWN

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) shares tumbled 20% to $10.90 after reporting interim results from ongoing 24-week Phase 2 study evaluating aldafermin in patients with NASH.

Shares of FuelCell Energy, Inc. (NASDAQ: FCEL) were down 10% to $0.3270 after the company filed for a common stock offering of up to 38 million shares.

Intersect ENT, Inc. (NASDAQ: XENT) was down, falling 10% to $15.30 after the company's ASCENT trial did not meet its primary endpoint.


In commodity news, oil traded up 1.9% to $53.80, while gold traded down 0.4% to $1,507.00.

Silver traded down 0.4% Monday to $17.56, while copper rose 0.9% to $2.585.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.74%, the Spanish Ibex Index rose 0.9%, while Italy’s FTSE MIB Index gained 0.8%. Meanwhile, the German DAX climbed 0.74%, and the French CAC 40 rose 0.59% while UK shares rose 0.59%.


Federal Reserve Chairman Jerome Powell will speak in Salt Lake City, Utah at 1:00 p.m. ET.

Data on consumer credit for August will be released at 3:00 p.m. ET.


Related Articles (AEMD + AKCA)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at